211 related articles for article (PubMed ID: 20801951)
1. Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes.
Fierz Y; Novosyadlyy R; Vijayakumar A; Yakar S; LeRoith D
Endocr Relat Cancer; 2010 Dec; 17(4):941-51. PubMed ID: 20801951
[TBL] [Abstract][Full Text] [Related]
2. Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression.
Fierz Y; Novosyadlyy R; Vijayakumar A; Yakar S; LeRoith D
Diabetes; 2010 Mar; 59(3):686-93. PubMed ID: 19959755
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin inhibits multiple stages of c-Neu/ErbB2 induced tumor progression in a transgenic mouse model of HER2-positive breast cancer.
Mosley JD; Poirier JT; Seachrist DD; Landis MD; Keri RA
Mol Cancer Ther; 2007 Aug; 6(8):2188-97. PubMed ID: 17699716
[TBL] [Abstract][Full Text] [Related]
4. Calorie restriction and rapamycin inhibit MMTV-Wnt-1 mammary tumor growth in a mouse model of postmenopausal obesity.
Nogueira LM; Dunlap SM; Ford NA; Hursting SD
Endocr Relat Cancer; 2012 Feb; 19(1):57-68. PubMed ID: 22143497
[TBL] [Abstract][Full Text] [Related]
5. mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes.
Fraenkel M; Ketzinel-Gilad M; Ariav Y; Pappo O; Karaca M; Castel J; Berthault MF; Magnan C; Cerasi E; Kaiser N; Leibowitz G
Diabetes; 2008 Apr; 57(4):945-57. PubMed ID: 18174523
[TBL] [Abstract][Full Text] [Related]
6. Effects of rapamycin on the mechanistic target of rapamycin (mTOR) pathway and telomerase in breast cancer cells.
Gopalakrishnan K; Venkatesan S; Low ESH; Hande MP
Mutat Res Genet Toxicol Environ Mutagen; 2018 Dec; 836(Pt B):103-113. PubMed ID: 30442335
[TBL] [Abstract][Full Text] [Related]
7. Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: potential role of attenuated oxidative stress and altered contractile protein expression.
Das A; Durrant D; Koka S; Salloum FN; Xi L; Kukreja RC
J Biol Chem; 2014 Feb; 289(7):4145-60. PubMed ID: 24371138
[TBL] [Abstract][Full Text] [Related]
8. The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001.
De Angel RE; Conti CJ; Wheatley KE; Brenner AJ; Otto G; Degraffenried LA; Hursting SD
Mol Carcinog; 2013 Jun; 52(6):446-58. PubMed ID: 22290600
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.
Namba R; Young LJ; Abbey CK; Kim L; Damonte P; Borowsky AD; Qi J; Tepper CG; MacLeod CL; Cardiff RD; Gregg JP
Clin Cancer Res; 2006 Apr; 12(8):2613-21. PubMed ID: 16638874
[TBL] [Abstract][Full Text] [Related]
10. Compensatory Increase of Transglutaminase 2 Is Responsible for Resistance to mTOR Inhibitor Treatment.
Cao J; Huang W
PLoS One; 2016; 11(2):e0149388. PubMed ID: 26872016
[TBL] [Abstract][Full Text] [Related]
11. Effects of intermittent and chronic calorie restriction on mammalian target of rapamycin (mTOR) and IGF-I signaling pathways in mammary fat pad tissues and mammary tumors.
Dogan S; Johannsen AC; Grande JP; Cleary MP
Nutr Cancer; 2011; 63(3):389-401. PubMed ID: 21462085
[TBL] [Abstract][Full Text] [Related]
12. mTOR partly mediates insulin resistance by phosphorylation of insulin receptor substrate-1 on serine(307) residues after burn.
Xin-Long C; Zhao-Fan X; Dao-Feng B; Wei D
Burns; 2011 Feb; 37(1):86-93. PubMed ID: 20594757
[TBL] [Abstract][Full Text] [Related]
13. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
[TBL] [Abstract][Full Text] [Related]
14. Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer.
Mroueh FM; Noureldein M; Zeidan YH; Boutary S; Irani SAM; Eid S; Haddad M; Barakat R; Harb F; Costantine J; Kanj R; Sauleau EA; Ouhtit A; Azar ST; Eid AH; Eid AA
FASEB J; 2019 Dec; 33(12):14051-14066. PubMed ID: 31661292
[TBL] [Abstract][Full Text] [Related]
15. Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes.
Novosyadlyy R; Lann DE; Vijayakumar A; Rowzee A; Lazzarino DA; Fierz Y; Carboni JM; Gottardis MM; Pennisi PA; Molinolo AA; Kurshan N; Mejia W; Santopietro S; Yakar S; Wood TL; LeRoith D
Cancer Res; 2010 Jan; 70(2):741-51. PubMed ID: 20068149
[TBL] [Abstract][Full Text] [Related]
16. mTORC1/2 targeted by n-3 polyunsaturated fatty acids in the prevention of mammary tumorigenesis and tumor progression.
Chen Z; Zhang Y; Jia C; Wang Y; Lai P; Zhou X; Wang Y; Song Q; Lin J; Ren Z; Gao Q; Zhao Z; Zheng H; Wan Z; Gao T; Zhao A; Dai Y; Bai X
Oncogene; 2014 Sep; 33(37):4548-57. PubMed ID: 24096482
[TBL] [Abstract][Full Text] [Related]
17. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
18. Ovariectomy is associated with metabolic impairments and enhanced mammary tumor growth in MKR mice.
Ben-Shmuel S; Scheinman EJ; Rashed R; Orr ZS; Gallagher EJ; LeRoith D; Rostoker R
J Endocrinol; 2015 Dec; 227(3):143-151. PubMed ID: 26383532
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin treatment benefits glucose metabolism in mouse models of type 2 diabetes.
Reifsnyder PC; Flurkey K; Te A; Harrison DE
Aging (Albany NY); 2016 Nov; 8(11):3120-3130. PubMed ID: 27922820
[TBL] [Abstract][Full Text] [Related]
20. Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.
Banerjee S; Gianino SM; Gao F; Christians U; Gutmann DH
Mol Cancer Ther; 2011 Feb; 10(2):279-91. PubMed ID: 21216928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
